27515307|t|Progestin suppressed inflammation and cell viability of tumor necrosis factor-α -stimulated endometriotic stromal cells
27515307|a|Endometriosis is an estrogen - dependent inflammatory disease. Progestins are a first-line treatment for endometriosis via activation of pituitary progesterone receptors and suppression of systemic estrogen: a less than optimal treatment. Increasing evidence is beginning to show that progestins may also influence local endometriotic cells, which may contribute to their clinical efficacy. Endometrial stromal cells (ESC) isolated from women with endometriosis were cultured with TNF-α to simulate an inflammatory environment. ESC were treated with the progestins, medroxyprogesterone acetate (MPA), norethisterone acetate (NETA), or dienogest (DNG) and cytokine mRNA production, protein secretion, and cell viability measured. DNG, NETA, and MPA suppressed the secretion of interleukin (IL)-6, IL-8, and monocyte chemotactic protein (MCP)-1 from ESC. DNG and NETA only reduced the TNF-α -stimulated mRNA production. All three progestins suppressed TNF-α -stimulated ESC proliferation. Progestins may influence endometriotic stromal cells altering the inflammatory microenvironment and their clinical efficacy.
27515307	0	9	Progestin	T103	UMLS:C0033306
27515307	38	52	cell viability	T038	UMLS:C1516362
27515307	56	79	tumor necrosis factor-α	T103	UMLS:C1456820
27515307	92	105	endometriotic	T038	UMLS:C0014175
27515307	106	119	stromal cells	T017	UMLS:C0162597
27515307	120	133	Endometriosis	T038	UMLS:C0014175
27515307	140	148	estrogen	T103	UMLS:C0014939
27515307	161	181	inflammatory disease	T038	UMLS:C1290884
27515307	183	193	Progestins	T103	UMLS:C0033306
27515307	200	220	first-line treatment	T058	UMLS:C1708063
27515307	225	238	endometriosis	T038	UMLS:C0014175
27515307	257	289	pituitary progesterone receptors	T103	UMLS:C0034833
27515307	294	326	suppression of systemic estrogen	T058	UMLS:C1535931
27515307	340	357	optimal treatment	T058	UMLS:C0087111
27515307	405	415	progestins	T103	UMLS:C0033306
27515307	441	454	endometriotic	T038	UMLS:C0014175
27515307	455	460	cells	T017	UMLS:C0597032
27515307	511	522	Endometrial	T017	UMLS:C0014180
27515307	523	536	stromal cells	T017	UMLS:C0162597
27515307	538	541	ESC	T017	UMLS:C0162597
27515307	557	562	women	T098	UMLS:C0043210
27515307	568	581	endometriosis	T038	UMLS:C0014175
27515307	601	606	TNF-α	T103	UMLS:C1456820
27515307	635	646	environment	T082	UMLS:C0014406
27515307	648	651	ESC	T017	UMLS:C0162597
27515307	674	684	progestins	T103	UMLS:C0033306
27515307	686	713	medroxyprogesterone acetate	T103	UMLS:C0065864
27515307	715	718	MPA	T103	UMLS:C0065864
27515307	721	743	norethisterone acetate	T103	UMLS:C0068980
27515307	745	749	NETA	T103	UMLS:C0068980
27515307	755	764	dienogest	T103	UMLS:C0057916
27515307	766	769	DNG	T103	UMLS:C0057916
27515307	775	783	cytokine	T103	UMLS:C0079189
27515307	784	799	mRNA production	T038	UMLS:C1158816
27515307	801	818	protein secretion	T038	UMLS:C1159339
27515307	824	847	cell viability measured	T062	UMLS:C2986858
27515307	849	852	DNG	T103	UMLS:C0057916
27515307	854	858	NETA	T103	UMLS:C0068980
27515307	864	867	MPA	T103	UMLS:C0065864
27515307	883	907	secretion of interleukin	T038	UMLS:C3155041
27515307	908	914	(IL)-6	T103	UMLS:C0021760
27515307	916	920	IL-8	T103	UMLS:C0079633
27515307	926	962	monocyte chemotactic protein (MCP)-1	T103	UMLS:C0128897
27515307	968	971	ESC	T017	UMLS:C0162597
27515307	973	976	DNG	T103	UMLS:C0057916
27515307	981	985	NETA	T103	UMLS:C0068980
27515307	1003	1008	TNF-α	T103	UMLS:C1456820
27515307	1021	1036	mRNA production	T038	UMLS:C1158816
27515307	1048	1058	progestins	T103	UMLS:C0033306
27515307	1070	1075	TNF-α	T103	UMLS:C1456820
27515307	1088	1105	ESC proliferation	T038	UMLS:C0596290
27515307	1107	1117	Progestins	T103	UMLS:C0033306
27515307	1132	1145	endometriotic	T038	UMLS:C0014175
27515307	1146	1159	stromal cells	T017	UMLS:C0162597
27515307	1160	1202	altering the inflammatory microenvironment	T033	UMLS:C0243095